| Knowledge and support—within your reach
|
|
|
|
|
Dear John Doe,
No matter how long you’ve been on therapy, Shared Solutions® can provide ways for you to stay current on the latest relapsing-remitting multiple sclerosis (RRMS) and COPAXONE® (glatiramer acetate injection) developments, while creating opportunities for you to meet others who are living with RRMS. Visit www.copaxone.com to find out about our upcoming programs and events
Valuable injection refresher training–one phone call away Shared Solutions® wants to help you feel as confident as possible with your COPAXONE® injections. Call us at 1-800-887-8100 and set up your free in-home refresher training session with a Shared Solutions® nurse. Let’s stay in touch! Participate in national teleconference discussions. Find events in your area. Learn more about skin-care strategies and best practices for injection techniques. Just call Shared Solutions® at 1-800-887-8100 to access a source of support, knowledge, and answers. Your Shared Solutions® Team 
Please see Important Safety Information about COPAXONE® below. Indication COPAXONE® (glatiramer acetate injection) is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis. Important Safety Information about COPAXONE® |
| • | Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol
|
||
| • | Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again
|
||
| • | Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense
|
||
| • | A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes
|
||
| • | The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®
|
||
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
Please see full Prescribing Information. Privacy Policy | Unsubscribe | Terms of Use | Contact Us 
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. Teva Neuroscience, Inc., Copaxone Marketing, 11100 Nall Avenue, Overland Park, Kansas 66211 © 2013 Teva Neuroscience, Inc. COP-40524 |
|||